BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 7
• 10
• 11
• 12
• 13
• 14
• 17
• 18
• 19
• 20
• 21
• 24
• 25
• 26
• 27
• 28

• Press Releases

  Forte Biosciences, Inc. to Present at Upcoming Healthcare Conferences

  November 3, 2025

   · 

  1 min read
• Press Releases

  Sanuwave Will Host a Conference Call on November 7, 2025 at 8:30 AM (ET) to Present Q3 2025 Financial Results

  November 3, 2025

   · 

  2 min read
• Press Releases

  Fulcrum Therapeutics to Present New Clinical Data from the PIONEER trial of Pociredir in Sickle Cell Disease at the 67th American Society of Hematology Annual Meeting

  November 3, 2025

   · 

  4 min read
• Press Releases

  Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - November 3, 2025

  November 3, 2025

   · 

  1 min read
• Press Releases

  DBV Technologies Appoints Industry Leader Kevin Trapp as Chief Commercial Officer

  November 3, 2025

   · 

  6 min read
• Press Releases

  Chiesi Global Rare Diseases and Protalix BioTherapeutics Seek Re-examination from the EMA for the Negative Opinion for Elfabrio (pegunigalsidase alfa) Alternative Dosing Regimen of Every Four Weeks in the EU

  November 3, 2025

   · 

  9 min read
• Press Releases

  Olema Oncology to Participate in Upcoming November 2025 Investor Conferences

  November 3, 2025

   · 

  1 min read
• Press Releases

  Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - November 3, 2025

  November 3, 2025

   · 

  2 min read
• Press Releases

  Aardvark Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - November 3, 2025

  November 3, 2025

   · 

  2 min read